The critical immunological feature of visceral leishmaniasis is the complete absence of cell mediated immunity to leishmanial antigens. Patients have been shown to have negative intradermal skin tests to Leishmanin, absent lymphocyte blastogenesis, and decreased IL-2 and IFN- gamma production in response to parasite antigens. Experimental models of visceral leishmaniasis suggest that the disease is characterized not by the lack of cytokine production per se, but by the production of potentially counter-protective cytokines. We sought to maximize assay sensitivity by using semi-quantitative RT-PCR techniques to analyze cytokine mRNA extracted from lesional tissue (bone marrow). In preliminary data we provide evidence that IL-lO mRNA is present at relatively high levels in active kala-azar, being at or below the limits of detectability after treatment, and absent in uninfected controls. The cellular source of this potentially down-regulatory cytokine is being investigated in patients from India by repeating the above experiments using bone marrow cells positively and negatively selected for B cells, T cells, or monocytes using magnetic beads. In in vitro macrophage infections, procyclics are killed by macrophage several hours post infection whereas metacyclics survive, transform to amastigotes and replicate. These different outcomes provide a good model for studying cellular responses elicited during infection that are associated with either intracellular killing or survival. L. major promastigotes induced remarkably weak cytokine responses by mouse macrophages during the early stage of infection and no dramatic differences were observed in the induction of cytokine mRNA expression by procyclic and metacyclic promastigotes. Both procyclic and metacyclic promastigotes downregulated cytokine gene expression by LPS-treated macrophages. This downregulation was more efficient in the case of metacyclics and this could be related to their survival. Significant differences were observed between procyclics and metacyclics in the activation of the oxidative burst. It seems likely that the oxidative burst is the major mechanism involved in the killing of procyclic promastigotes. These results suggest that activation pathways leading to oxygen-dependent and independent killing mechanisms can be triggered independently in Leishmania infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000494-07
Application #
3768810
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Peters, Nathan C; Kimblin, Nicola; Secundino, Nagila et al. (2009) Vector transmission of leishmania abrogates vaccine-induced protective immunity. PLoS Pathog 5:e1000484
Peters, Nathan C; Egen, Jackson G; Secundino, Nagila et al. (2008) In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321:970-4
Nylen, Susanne; Sacks, David (2007) Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28:378-84
Huynh, Chau; Sacks, David L; Andrews, Norma W (2006) A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomes. J Exp Med 203:2363-75
Iborra, Salvador; Carrion, Javier; Anderson, Charles et al. (2005) Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice. Infect Immun 73:5842-52
Tabbara, Khaled S; Peters, Nathan C; Afrin, Farhat et al. (2005) Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection. Infect Immun 73:4714-22
Anderson, Charles F; Mendez, Susana; Sacks, David L (2005) Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J Immunol 174:2934-41
Flynn, Barbara; Wang, Vivian; Sacks, David L et al. (2005) Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs. Infect Immun 73:4948-54
Seder, Robert A; Sacks, David L (2004) Memory may not need reminding. Nat Med 10:1045-7
Sacks, David; Anderson, Charles (2004) Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol Rev 201:225-38

Showing the most recent 10 out of 28 publications